Shares of Gilead Sciences Inc. VALID, -0.09% won 0.3% in premarket trading on Tuesday after the drugmaker announced a deal worth more than $ 6 billion with Tango Therapeutics on Monday night. The collaboration, which began in 2018, has been expanded to allow access rights for Gilead on 15 programs …
Read More »Gilead announces another cancer campaign
